The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
dc.contributor.author | Ar, M. Cem | |
dc.contributor.author | Buyuktas, Deram | |
dc.contributor.author | Eskazan, A. Emre | |
dc.contributor.author | Aydin, Seniz Ongoren | |
dc.contributor.author | Tanrikulu, Eda | |
dc.contributor.author | Baslar, Zafer | |
dc.contributor.author | Buyru, A. Nur | |
dc.date.accessioned | 2024-04-24T17:27:44Z | |
dc.date.available | 2024-04-24T17:27:44Z | |
dc.date.issued | 2012 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: Bone marrow fibrosis is the second most common complication that causes morbidity and mortality in patients with Philadelphia-negative myeloproliferative neoplasms (MPNs). The aim of this study was to investigate the association between JAK2V617F mutation and bone marrow fibrosis at diagnosis in patients with MPNs. Material and Methods: In total, 149 patients with MPNs were retrospectively evaluated to determine if there was an association between the histological grade of bone marrow fibrosis and JAK2V617F mutation. Results: In all, 67.7% of the patients carried the mutated JAK2 gene. The presence of JAK2V617F mutation was not associated with the occurrence of bone marrow fibrosis (P = 0.55) or its grade at diagnosis (P = 0.65). Conclusion: Molecular mechanisms or genetic defects other than JAK2V617F may underlie the occurrence of bone marrow fibrosis in patients with MPNs. | en_US |
dc.identifier.doi | 10.5505/tjh.2012.58751 | |
dc.identifier.endpage | 247 | en_US |
dc.identifier.issn | 1300-7777 | |
dc.identifier.issn | 1308-5263 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 24744667 | |
dc.identifier.startpage | 242 | en_US |
dc.identifier.uri | https://doi.org/10.5505/tjh.2012.58751 | |
dc.identifier.uri | https://hdl.handle.net/11468/20165 | |
dc.identifier.volume | 29 | en_US |
dc.identifier.wos | WOS:000313935800007 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Galenos Yayincilik | en_US |
dc.relation.ispartof | Turkish Journal of Hematology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Jak2v617f | en_US |
dc.subject | Myeloproliferative Disease | en_US |
dc.subject | Bone Marrow Fibrosis | en_US |
dc.title | The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms | en_US |
dc.title | The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms | |
dc.type | Article | en_US |